CARY STREET PARTNERS INVESTMENT ADVISORY LLC
Position in LLY — ELI LILLY & Co
CIK 1766904
RICHMOND, VA
Position in LLY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$3,421,967
+$846,619 QoQ
Shares Held
2,853
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#2,012
of 4,605 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $10,872,180 across 13 Drug Manufacturers - General names. LLY ranks #1 (31.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
2,853 | $3,421,967 | |
| 2 | ABBV |
AbbVie Inc.
|
9,052 | $2,277,835 | |
| 3 | JNJ |
Johnson & Johnson
|
5,727 | $1,454,479 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,104 | $1,041,359 | |
| 5 | AMGN |
Amgen Inc
|
2,175 | $787,606 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,702 | $467,705 | |
| 7 | NVS |
Novartis AG
|
2,406 | $377,067 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,072 | $349,863 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,421,967 | 2,853 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $2,575,348 | 2,800 | Shares | Other | 2026-04-29 | |
| 2025-12-31 | $2,890,881 | 2,690 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $1,762,530 | 2,310 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $1,777,323 | 2,280 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,853,338 | 2,244 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $1,577,968 | 2,044 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $22,880,281 | 25,826 | Shares | Defined | 2024-10-30 | |
| 2024-06-30 | $23,395,920 | 25,841 | Shares | Other | 2024-07-22 | |
| 2024-03-31 | $20,414,444 | 26,241 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $15,598,935 | 26,760 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $13,980,955 | 26,029 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,059,351 | 25,714 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $9,363,002 | 27,264 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,187,180 | 27,846 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,262,684 | 28,646 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,680,934 | 26,774 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,605,394 | 9,098 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,379,635 | 8,615 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,911,938 | 8,275 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,923,836 | 8,382 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,188,548 | 6,362 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,965,466 | 11,641 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $980,040 | 6,621 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||